Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Daniel J Olson"'
Autor:
Daniel J Olson, Christopher Rodman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/c45845dbb5e649579bbc1b3f45834a2b
Autor:
Marcus Butler, Daniel J Olson, Antonio Giordano, Ecaterina Dumbrava, Benjamin Schlechter, Maria Apostolopoulou, Mridula George, Brooke Pieke, Kara Moss, Deyaa Adib, Sam Saibil, Miriam Gavriliuc, Emily Lichtenstein, Jill Geisberger, D’Arcy Kirkwood, Salina Dang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/cf29e91daea2452aafdbe685d05a5333
Autor:
Daniel J Olson, Ecaterina Dumbrava, Benjamin Schlechter, Maria Apostolopoulou, Kara Moss, Deyaa Adib, Sam Saibil, Martin Gutierez, Syma Iqbal, Davendra Sohal
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/05a7d050fb7d400abbb74c73c3adc8a9
Autor:
Thomas F Gajewski, Jason J Luke, Daniel J Olson, Padma Rajagopal, Melissa Y Tjota, Girish Venkataraman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background The combination of the immune checkpoint inhibitors (ICIs) ipilimumab and nivolumab is a mainstay of treatment for selected patients with metastatic melanoma. This combination also results in more frequent immune-related adverse events (ir
Externí odkaz:
https://doaj.org/article/2f1158af9caf4f33b3aaae268a4275b8
Autor:
Daniel J. Olson, Jason J. Luke
Publikováno v:
Clinical Cancer Research. 29:1167-1169
Summary Myeloid-derived suppressor cells (MDSC) are associated with resistance to anti-PD-1 therapies. All-trans retinoic acid (ATRA) may induce maturation of MDSCs and alter their immunosuppressive effects. Adding ATRA to pembrolizumab may target th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2001f0ed38c7129c7b488abd64370ca
https://doi.org/10.1158/1078-0432.ccr-22-3652
https://doi.org/10.1158/1078-0432.ccr-22-3652
Autor:
Ahmed E. Hozain, Chase Corvin, Huihua Li, Kylie Zane, Timothy McGinnis, Daniel J. Olson, Phillip P. Connell, Maria Lucia L. Madariaga
Publikováno v:
Annals of Thoracic Surgery Short Reports.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0382d4758152a6a405f722f1026026b1
https://doi.org/10.1016/j.atssr.2023.04.006
https://doi.org/10.1016/j.atssr.2023.04.006
Autor:
Thomas F. Gajewski, Yuanyuan Zha, Daniel J. Olson, Sherin J. Rouhani, Jovian Yu, Jason W. Shapiro, Robin Reschke
Supplementary Data from Checkpoint Blockade–Induced Dermatitis and Colitis Are Dominated by Tissue-Resident Memory T Cells and Th1/Tc1 Cytokines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::172958b03236321b1bbbe9c7fa3771a1
https://doi.org/10.1158/2326-6066.22545426.v1
https://doi.org/10.1158/2326-6066.22545426.v1
Autor:
Thomas F. Gajewski, Yuanyuan Zha, Daniel J. Olson, Sherin J. Rouhani, Jovian Yu, Jason W. Shapiro, Robin Reschke
Immune checkpoint blockade is therapeutically successful for many patients across multiple cancer types. However, immune-related adverse events (irAE) frequently occur and can sometimes be life threatening. It is critical to understand the immunologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ea5834e9011b18c90f7370d48a4cf17
https://doi.org/10.1158/2326-6066.c.6550938
https://doi.org/10.1158/2326-6066.c.6550938
Autor:
Gary K. Schwartz, Pamela N. Munster, David Hogg, Marcus O. Butler, Bruno R. Bastos, Brian W. Labadie, Timothy Carll, Yuanyuan Zha, Riyue Bao, Carrie A. Strand, Jacob B. Allred, Daniel J. Olson, Jason J. Luke
Purpose:The surface receptor MET is highly expressed on primary uveal melanoma; MET inhibitors demonstrated early clinical signals of efficacy in slowing uveal melanoma growth. The primary objective of our study was to compare the progression-free su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49a72ce6a3b59c8d4549ae363e81ad70
https://doi.org/10.1158/1078-0432.c.6528707
https://doi.org/10.1158/1078-0432.c.6528707
Autor:
Gary K. Schwartz, Pamela N. Munster, David Hogg, Marcus O. Butler, Bruno R. Bastos, Brian W. Labadie, Timothy Carll, Yuanyuan Zha, Riyue Bao, Carrie A. Strand, Jacob B. Allred, Daniel J. Olson, Jason J. Luke
This includes Supplementary Table 1 with all adverse events by arm. Supplementary Figure 1 shows best overall response in patients with restaging imaging. Supplementary Figure 2 shows all somatic mutations, including those identified in an explorator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3feab2d7540101303aabf56123c54a64
https://doi.org/10.1158/1078-0432.22474166.v1
https://doi.org/10.1158/1078-0432.22474166.v1